However, it is becoming increasingly apparent that many individuals with asthma have at least a component of co-existing non-T2, corticosteroid insensitive airways inflammation (e.g. IL-6, IL-17 and neutrophilic) that continues to drive poor asthma control even after all currently available approaches have been exhausted [4]. This evidence concerns the gene IL6 and asthma.